Lewis Toni-Ann J, Kostanyan Sofya, Kasmin Franklin
Internal Medicine, New York-Presbyterian Brooklyn Methodist Hospital, Brooklyn, USA.
Gastroenterology, New York-Presbyterian Brooklyn Methodist Hospital, Brooklyn, USA.
Cureus. 2023 Jul 4;15(7):e41351. doi: 10.7759/cureus.41351. eCollection 2023 Jul.
Brunner's gland hyperplasia is an uncommon pathology from the duodenum and is believed to be associated with infection with . Patients commonly present with gastrointestinal bleeding, nausea, or abdominal pain. However, obstruction is an unusual clinical finding. A 47-year-old male presented to the emergency department with complaints of recurrent emesis, epigastric pain, and cramping for three days. Medical history was significant for duodenitis and diverticulitis, but there had been no prior abdominal surgeries. Epigastric tenderness to palpation without rebound tenderness was present on physical examination, stool antigen was positive on admission, and treatment with triple therapy was initiated. Progressively the patient developed increasing emesis, with an associated cessation in flatus and bowel movements. On endoscopy, it was reported that the endoscope could not advance past the second portion of the duodenum. A nasogastric tube was placed for gastric decompression. Small bowel follow-through showed obstruction at the distal second duodenal segment. Bismuth quadruple therapy was initiated on day three. Push enteroscopy showed luminal narrowing and a transition point at the second duodenal segment with no identifiable mass or significant ulceration. Biopsy reports indicated Brunner's gland hyperplasia. By day seven, the patient reported increased bowel movements and flatus, with a resolution of his nausea and emesis, and the nasogastric tube was removed. The patient was discharged on day eight with outpatient prescriptions for quadruple therapy for six days. He was also instructed to follow up with the general surgery and gastroenterology teams for outpatient colonoscopy six weeks post-discharge and with his primary care physician (PCP) four weeks after completing quadruple therapy to ensure eradication. Studies have shown that were detected in most patients with Brunner's gland hyperplasia and may induce proliferation in Brunner's glands. Brunner's gland hyperplasia has a low incidence, with minimal cases reported. There is malignant potential but a low risk of progression into adenocarcinoma. Our case reinforces the idea that Brunner's gland hyperplasia should be included in the work-up, alongside testing for infection with in assessing patients with gastric obstruction.
布伦纳腺增生是一种源于十二指肠的罕见病理情况,据信与 感染有关。患者通常表现为胃肠道出血、恶心或腹痛。然而,梗阻是一种不常见的临床发现。一名47岁男性因反复呕吐、上腹部疼痛和绞痛三天而到急诊科就诊。病史中十二指肠炎症和憩室炎较为显著,但此前没有腹部手术史。体格检查发现上腹部触诊有压痛但无反跳痛,入院时粪便抗原呈阳性,遂开始三联疗法治疗。患者逐渐出现呕吐加重,同时伴有排气和排便停止。在内镜检查中,报告称内镜无法通过十二指肠第二部。放置了鼻胃管进行胃减压。小肠造影显示十二指肠第二段远端梗阻。第三天开始使用铋剂四联疗法。推进式小肠镜检查显示十二指肠第二段管腔狭窄并有一个移行点,未发现可识别的肿块或明显溃疡。活检报告显示为布伦纳腺增生。到第七天,患者报告排便和排气增多,恶心和呕吐症状缓解,鼻胃管被拔除。患者在第八天出院,带了六天的门诊四联疗法处方。还指示他出院六周后到普通外科和胃肠病学团队进行门诊结肠镜检查,并在完成四联疗法四周后与他的初级保健医生随访,以确保根除。研究表明,大多数布伦纳腺增生患者中检测到 ,并且可能诱导布伦纳腺增生。布伦纳腺增生发病率低,报告的病例极少。有恶变潜能,但进展为腺癌的风险较低。我们的病例强化了这样一种观点,即在评估胃梗阻患者时,布伦纳腺增生应纳入检查范围,同时进行 感染检测。